相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defective Regulation of Autophagy upon Leucine Deprivation Reveals a Targetable Liability of Human Melanoma Cells In Vitro and In Vivo
Joon-Ho Sheen et al.
CANCER CELL (2011)
Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1
S. Huber et al.
LEUKEMIA (2011)
Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
Kuen-Feng Chen et al.
CLINICAL CANCER RESEARCH (2010)
Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis
Sameer A. Parikh et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Lysosome Dysfunction Triggers Atg7-dependent Neural Apoptosis
Ken C. Walls et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
Laura Bonapace et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma
Satoshi Shimizu et al.
JOURNAL OF HEPATOLOGY (2010)
Melanoma Differentiation Associated Gene-7/Interleukin-24 Potently Induces Apoptosis in Human Myeloid Leukemia Cells through a Process Regulated by Endoplasmic Reticulum Stress
Mohamed Rahmani et al.
MOLECULAR PHARMACOLOGY (2010)
Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK
F. McCoy et al.
CELL DEATH & DISEASE (2010)
The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways
Mohamed Rahmani et al.
BLOOD (2009)
Sorafenib Induces Apoptosis Specifically in Cells Expressing BCR/ABL by Inhibiting Its Kinase Activity to Activate the Intrinsic Mitochondrial Pathway
Tetsuya Kurosu et al.
CANCER RESEARCH (2009)
BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
Shengbing Huang et al.
CLINICAL CANCER RESEARCH (2009)
BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing
Aditi Pandya Martin et al.
MOLECULAR PHARMACOLOGY (2009)
Human Melanoma Cells under Endoplasmic Reticulum Stress Are More Susceptible to Apoptosis Induced by the BH3 Mimetic Obatoclax
Chen Chen Jiang et al.
NEOPLASIA (2009)
Autophagy plays a protective role during zVAD-induced necrotic cell death
You-Tong Wu et al.
AUTOPHAGY (2008)
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
Marina Konopleva et al.
CANCER RESEARCH (2008)
A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies
Aaron D. Schimmer et al.
CLINICAL CANCER RESEARCH (2008)
Mutant FLT3:: A direct target of sorafenib in acute myelogenous leukemia
Weiguo Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway
W. Zhang et al.
LEUKEMIA (2008)
A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
In Hye Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
GSK-3β inhibition enhances sorafenib-induced apoptosis in melanoma cell lines
David J. Panka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
Mai Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MCL-1 as a buffer for proapoptotic BCL-2 family members during TRAIL-induced apoptosis - A mechanistic basis for sorafenib (bay 43-9006)-induced trail sensitization
Xue Wei Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma:: evidence for contribution to apoptosis resistance
N. Zantl et al.
ONCOGENE (2007)
The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with mcl-1 and cFLIPL down-regulation
Roberto R. Rosato et al.
CANCER RESEARCH (2007)
The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress
Mohamed Rahmani et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Reduction of TRAIL-induced McI-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death
M. Stacey Ricci et al.
CANCER CELL (2007)
LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy
Akiko Kuma et al.
AUTOPHAGY (2007)
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Suzanne Trudel et al.
BLOOD (2007)
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak
Patricia Perez-Galan et al.
BLOOD (2007)
Structural insights into the degradation of Mcl-1 induced by BH3 domains
Peter E. Czabotar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antitumor activity of sorafenib in FLT3-driven leukemic cells
D. Auclair et al.
LEUKEMIA (2007)
The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant Bcr/Abl(+) human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation
Mohamed Rahmani et al.
MOLECULAR PHARMACOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Hyungjin Kim et al.
NATURE CELL BIOLOGY (2006)
Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma
I Sturm et al.
CELL DEATH AND DIFFERENTIATION (2006)
Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation
M Rahmani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006
CR Yu et al.
ONCOGENE (2005)
Endogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cells
P Gomez-Bougie et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
AM Domina et al.
ONCOGENE (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
D Nijhawan et al.
GENES & DEVELOPMENT (2003)
The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-α-mediated process
M Rahmani et al.
EXPERIMENTAL CELL RESEARCH (2002)
Analysis of p53/BAX/p16ink4a/CDKN2 in esophageal squamous cell carcinoma:: High BAX and p16nk4a/CDKN2 identifies patients with good prognosis
I Sturm et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
